Cargando…
6-sialyllactose ameliorates dihydrotestosterone-induced benign prostatic hyperplasia through suppressing VEGF-mediated angiogenesis
Benign prostatic hyperplasia (BPH), a common disease in elderly males, is accompanied by non-malignant growth of prostate tissues, subsequently causing hypoxia and angiogenesis. Although VEGF-related angiogenesis is one of the therapeutic targets of prostate cancer, there is no previous study target...
Autores principales: | Kim, Eun-Yeong, Jin, Bo-Ram, Chung, Tae-Wook, Bae, Sung-Jin, Park, Hyerin, Ryu, Dongryeol, Jin, Ling, An, Hyo-Jin, Ha, Ki-Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774418/ https://www.ncbi.nlm.nih.gov/pubmed/31383249 http://dx.doi.org/10.5483/BMBRep.2019.52.9.113 |
Ejemplares similares
-
6′-Sialyllactose Ameliorates In Vivo and In Vitro Benign Prostatic Hyperplasia by Regulating the E2F1/pRb–AR Pathway
por: Jin, Bo-Ram, et al.
Publicado: (2019) -
Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression
por: Chung, Tae-Wook, et al.
Publicado: (2017) -
3′‐Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis
por: Kang, Li‐Jung, et al.
Publicado: (2018) -
Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis
por: Jin, Bo-Ram, et al.
Publicado: (2020) -
Umbelliferone Ameliorates Benign Prostatic Hyperplasia by Inhibiting Cell Proliferation and G1/S Phase Cell Cycle Progression through Regulation of STAT3/E2F1 Axis
por: Kim, Hyo-Jung, et al.
Publicado: (2021)